![Richard Steinhart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Steinhart
Directeur/Membre du Conseil chez
ACTINIUM PHARMACEUTICALS, INC.
Fortune : 22 510 $ au 31/10/2026
Profil
Mr. Richard I.
Steinhart is an Independent Director at Atossa Therapeutics, Inc. and an Independent Director at Actinium Pharmaceuticals, Inc. He is on the Board of Directors at Atossa Therapeutics, Inc. and Actinium Pharmaceuticals, Inc. Mr. Steinhart was previously employed as a Senior VP, Chief Financial & Accounting Officer by BioXcel Therapeutics, Inc., a Chief Financial Officer & Vice President by Remedy Pharmaceuticals, Inc., a CFO, Secretary, Treasurer & Senior VP-Finance by MELA Sciences, Inc., an Independent Director by Manhattan Pharmaceuticals, Inc., a Managing Director by Forest Street Capital, LLC, a Chief Financial Officer & Vice President by Emisphere Technologies, Inc., a Chief Financial Officer & General Partner by CW Group, Inc., and a Managing Director by SAE Ventures.
He received his undergraduate degree from Pace University and an MBA from Pace University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/05/2026 | 10 000 ( 0,1% ) | 21 700 $ | 31/10/2026 | |
| 02/10/2026 | 316 ( 0% ) | 468 $ | 31/10/2026 | |
| 15/06/2026 | 26 335 ( 0,18% ) | 342 $ | 31/10/2026 |
Postes actifs de Richard Steinhart
| Sociétés | Poste | Début |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 08/11/2013 |
| ATOSSA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/03/2014 |
Anciens postes connus de Richard Steinhart
| Sociétés | Poste | Fin |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Directeur Financier/CFO | 31/10/2026 |
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops molecule drugs for acute central nervous system disorders | Directeur Financier/CFO | 01/04/2017 |
| STRATA SKIN SCIENCES, INC. | Directeur Financier/CFO | 31/12/2013 |
| TG THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2012 |
Forest Street Capital, LLC | Corporate Officer/Principal | 24/04/2006 |
Formation de Richard Steinhart
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
STRATA Skin Sciences, Inc.
 STRATA Skin Sciences, Inc. Medical SpecialtiesHealth Technology Manufactures dermatology treatment products | Health Technology |
Atossa Therapeutics, Inc.
 Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops molecule drugs for acute central nervous system disorders | Health Technology |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Forest Street Capital, LLC | |
SAE Ventures | |
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
